Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis

NCT00665925 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

457

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Fostamatinib disodium (R935788)
DRUG: Fostamatinib disodium (R935788)
DRUG: Placebo

Sponsor

Rigel Pharmaceuticals